DRUG NEWS: Statin under fire

June 2004 
Volume 34  Number 6
Pages 30 - 30
  PDF Version Available!

© 2004 Lippincott Williams & Wilkins, Inc. Volume 34(6)             June 2004             p 30 Statin under fire [DRUG NEWS: LIPID-LOWERING DRUG]

The consumer group Public Citizen has filed a petition with the FDA seeking to remove Crestor (rosuvastatin) from the market because of dangerous adverse reactions. Crestor, a lipid-lowering drug, was first marketed in the United States in September 2003. Since then, seven patients developed rhabdomyolysis, a potentially fatal condition involving the breakdown of muscle tissue, and nine experienced kidney failure or damage. One woman died from rhabdomyolysis and kidney damage.

Rhabdomyolysis is a potential complication of all statin drugs. In 2001, the FDA removed another statin, Baycol, from the market because of several deaths from rhabdomyolysis worldwide.

Crestor won FDA approval despite concerns about its potential to cause rhabdomyolysis, ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

Featured Jobs

Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member